MedTrace Logo

Thromboelastogram in Postdelivery Preeclamptic Patients

NCT03555630 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-03-24

No results posted yet for this study

Summary

There are no studies evaluating the effect of aging on hemostasis of preeclamptic patients. Additionally, although there are some studies that establish normal reference values for TEG profiles in healthy term pregnant patients, conflicting results have been found in preeclampsia. Reference values are important to establish baseline parameters in cases of pre-eclampsia complicated by postpartum hemorrhage. The investigators will evaluate reference values for TEG in postdelivery preeclamptic patients and the difference between vaginal delivery and cesarean section.

Conditions

Interventions

DIAGNOSTIC_TEST

Thromboelastogram

Blood sample processing for thromboelastogram

Sponsors & Collaborators

  • Augusta University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-22
Primary Completion
2019-10-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03555630 on ClinicalTrials.gov